INTRODUCTION
The Challenge phage system is a genetic approach for characterizing DNA-protein interactions. The principle behind the method is to place the expression of a phage reporter gene under the control of a specific DNA-protein interaction (1) (2) (3) . This approach can be applied to a wide variety of DNA binding proteins because most specific DNA-binding proteins can act as repressors if their binding sites are placed close enough to the promoter (4) . The system has also been adapted to study RNA-protein interactions (5, 6) .
Challenge phage use the P22 ant gene as the reporter. The phages are engineered so that expression of ant determines the lysis-lysogeny decision of P22 (7) . Expression of ant is controlled by a specific DNAinteraction which provides a simple, sensitive genetic selection for mutations in the DNA binding site that increase or decrease the strength of the DNA-protein interaction. These features provide general methods for measuring relative in vivo affinities of DNA-binding proteins for target sites and for identifying specific base-pairs in DNA that contact the protein. In addition, challenge phages can be constructed where ant expression is regulated by the assembly of nucleoprotein complexes containing several different proteins (8, 9) . This feature provides a method to define cooperative interactions between DNA-binding proteins and to analyze the abilities of mutant proteins to form complexes.
P22 has two regulatory regions that control the decision between lysis and lysogeny (10, 11) . One region, called immC, encodes the c2 repressor which represses transcription from the P L and P R promoters. The c2 repressor is required both to establish and maintain lysogeny. P22 also has a second regulatory region, called immI, which contains the ant (antirepressor), arc (antirepressor control) and mnt (maintenance) genes. Ant binds noncovalently to c2 repressor and inactivates it. Expression of Ant is negatively regulated by the Arc and Mnt proteins.
Challenge phages have three alterations in the immI region that affect the lysis-lysogeny decision. They contain a cassette encoding kanamycin resistance (Kan R ) in the mnt gene, an arc(Am) mutation that inactivates Arc, and a substitution of a DNA-binding site for Omnt. Binding of the cognate protein to the substituted site is the only method of regulating transcription from Pant and thus controls the decision between lysis and lysogeny. If no protein is bound to the substituted site, ant is expressed and the infected host cell is lysed. If the protein binds to the site, ant expression is repressed and the phage forms a Kan
EcoRI sites. Blunt-ended DNA fragments such as complementary oligonucleotides or restriction fragments can be cloned into the SmaI site. This places the insert 3 bp upstream of the initiation site of Pant. The presence of the insert can be easily verified by PCR analysis.
The substitution in pPY190 can be moved onto P22 mnt::Kan arc(Am) (P22-1000) by homologous recombination in vivo. A host containing the plasmid is infected with the phage and a lysate is prepared. During lytic growth, the phage and the plasmid can undergo recombination between the sequence homology on the plasmid and the phage. Recombinant phage that contain the substituted DNA-binding site in place of Omnt can be identified by infecting a MS1582 cells. MS1582 contains a P22 prophage which expresses the c2 and Mnt proteins. Mnt represses Omnt of incoming parental phages preventing lytic growth. In contrast, phages carrying the substituted DNA-binding site are not repressed by Mnt and thus express Ant, forming plaques. The frequency of recombination between the phage and plasmid is high. Typically between 10 -20% of the progeny phage are recombinants. One caveat is that if the Salmonella host chromosome encodes the protein that recognizes the DNA-binding site, it should be mutated so that the protein does not repress the challenge phage.
Since the parental phage carries the arc(Am) mutation and the pPY190 plasmid contains the wild-type allele, recombinants are either arc(Am) or arc + depending upon which side of the mutation the crossover occurred. Both types of recombinants form plaques on MS1582. The arc + recombinants form small, turbid plaques because Arc can partially repress Pant. The arc(Am) recombinants form large, clear plaques which can be purified and used in subsequent experiments.
The desired recombinants contain both the DNA binding site and the arc(Am) mutation. The Omnt substitutiton in pPY190 contains an EcoRI site that is not present in the parental phage, and the arc(Am) mutation destroys a Fnu4H site (Figure 2 ). Thus the desired recombinants can be confirmed by PCR amplification of the immI region followed by restriction fragment length polymorphism (RFLP) mapping with EcoRI and Fnu4H (Figure 3 ).
Essentially any DNA binding site can be cloned into pPY190 and recombined onto P22 to form a challenge phage. It is also possible to clone large fragments that contain multiple DNA-binding sites. For simple DNA-protein interactions the extent of repression of Pant by a DNA-binding protein depends upon the proximity of the protein to the transcription start site. For example, a consensus λ cI binding site functions well when placed at the +1 or +4 position but does promote repression when placed at position +24 (4). It is also possible to construct phages where DNA looping regulates expression from Pant. In the case of the λ attL site, repression required an IHF-mediated loop containing an Int protein monomer bound simultaneously to both the Pant region and a sequence more than 50 bp downstream of Pant (14) .
Construction of challenge phage by in vivo recombination
1. Grow the MS1883 containing a pPY190 subclone with the desired DNA-binding site in LB-broth + Amp at 37°C overnight. 2. Mix 10 6 -10 7 plaque forming units (pfu) of P22 mnt::Kan9 arc(Am) phage with 50 µl of the overnight culture. Leave at room temperature for 15-20 min to allow phage adsorption. 3. Add 2 ml LBEG and grow at 37°C with vigorous aeration for 3 h or until the culture is lysed. 4 . Add several drops of chloroform and vortex thoroughly. Allow the chloroform to settle. Pour the supernatant (avoiding the chloroform) into a microfuge tube. Centrifuge 2 min in a microfuge to pellet the cell debris. 5. Transfer the supernatent to a new tube, add a few drops of chloroform, vortex, and allow the chloroform to settle. Store the lysate at 4°C. 6. Dilute the lysate 1/100 by adding 10 µl to 1 ml LB-broth. Vortex. Mix 0.2 ml of the diluted lysate with 0.1 ml of a fresh overnight culture of MS1582 (to give a MOI < 1). 7. Leave at room temperature for 15-20 min to allow phage adsorption. 8. Add 3 ml of melted TBSA to a test tube, place in a 50°C heating block, and allow the temperature of the TBSA to equilibrate to 50°C. 9. Add 3 ml TBSA to the cells + phage, mix, and quickly pour onto a LB-agar plate. Allow the top agar to solidify at room temperature then incubate overnight at 37°C. 10. Pick large clear plaques with sterile toothpicks and streak for isolation on a LB-agar plate overlayed with 3 ml TBSA containing 0.1 ml of fresh MS1582. Incubate overnight at 37°C. 11. Pick large, clear, well isolated plaques and streak for isolation on a LB-agar plate overlayed with 3 ml TBSA containing 0.1 ml of fresh MS1883. Incubate overnight at 37°C. 12. Pick and restreak the large, clear plaques. Incubate overnight at 37°C. The larger, clear plaques contain potential recombinant challenge phage.
Identification of challenge phage recombinants by RFLP mapping. The desired challenge phage recombinants have a restriction fragment length polymorphism (RFLP) that can be identified by digesting the immI PCR fragment with EcoR1 or Fnu4H1.
Preparation of challenge phage lysates
1. For each potential recombinant challenge phage to be tested, add 0.1 ml of MS1883 to 5 ml LBEG. Prepare an identical culture as a control. Incubate on a shaker at 37°C until the cells reach early exponential phase (about 1-2 h). 2. Using a sterile pasteur pipet, plug an independent, well isolated, large clear plaque from the potential challenge phage and add 1 plaque to each tube of MS1883. To the control culture, add a plaque of the P22-1000 parental phage. Incubate at 37°C with vigorous aeration for about 3 h or until lysed. 3. Add several drops of chloroform, vortex, allow the chloroform to settle, then transfer the supernatent (avoiding the chloroform) to microfuge tubes. Centrifuge for 2 min in a microfuge to pellet the cell debris. 5. Transfer the supernatent from each phage into clean microfuge tubes. Centrifuge for 30 min at 4°C in a microfuge to pellet the phage. 6. Carefully pour off the supernatent. Add 0.1 ml 0.85% NaCl to each phage pellet and vortex to resuspend the phage. Combine the supernatents from a single phage into one tube. Add several drops of chloroform and vortex. Store the concentrated lysate at 4°C.
PCR and RFLP analysis
1. Phage lysates can be amplified directly without purifying phage DNA. Include the parent P22-1000 and a challenge phage with the Pant region of pPY190 recombined onto P22 arc(Am) as controls. DNA-binding site mutants may result from spontaneous mutagenesis. However, spontaneous mutants are often due to deletion mutations which are less valuable for defining DNA-protein interactions than point mutations. The frequency of point mutations may be enhanced by mutagenizing the phage. It is useful to use several mutagens with different specificities to obtain a wide spectrum of mutations (13) . Two methods of mutagenesis that are particularly useful are UV mutagenesis and hydroxylamine mutagenesis. Phage can be directly treated with both of these mutagens in vitro.
Using this approach, it is possible to quickly isolate a large number of O c mutations in the substituted DNA-binding site. The resulting mutations define critical residues of the DNA-binding site necessary for recognition by a DNA-binding protein. Many DNA-binding sites are palindromes bound by identical subunits of dimeric regulatory proteins: each monomer recognizes one of the half-sites. For palindromic DNA-binding sites, it may be necessary to construct symmetric double mutants to determine their effect on DNA binding. Such symmetric, double mutants can be constructed by cloning the appropriate double stranded oligonucleotide into the SmaI site of pPY190 to yield the corresponding challenge phage.
In the following procedure, the challenge phage are mutagenized with UV light. A S. typhimurium strain carrying a plasmid which expresses the cognate DNA-binding protein and a second compatible plasmid carrying the mucA + B + genes is infected with the irradiated phage. The mucAB gene products increase the frequency of error prone repair of UV induced DNA damage. Clear plaque mutations that inactivate the binding site will be rare (typically about 10 -6 to 10 -7 ) and the background will have numerous faint turbid plaques. Therefore it is necessary to plaque purify the clear plaque mutants several times.
Isolation of mutations in a DNA-binding site
1. Grow an overnight culture of the MST2781 cells with the P tac -DNA-binding protein expression plasmid in 2 ml LB-broth + Tet + antibiotic at 37°C. 2. Subculture 0.1 ml of the overnight culture into 2 ml LB-broth + Tet + antibiotic. Incubate with vigorous aeration at 37°C for 2-3 h or until mid-exponential phase. 3. Dilute 0.5 ml of the mid-exponential phase culture into 1.5 ml LB-broth + Tet + antibiotic + IPTG.
Incubate the cells for 1-2 h with vigorous aeration at 37°C. 4. Dilute the challenge phage to approximately 10 9 pfu/ml in 0.85% NaCl (final volume needed is 1 ml). Save 0.5 ml of the diluted phage as a control. 5. Place 0.5 ml of the diluted phage in a small sterile petrie dish, remove the lid, and UV irradiate to 12,000 µJ/cm 2 . 6. Prepare serial 10 -1 and 10 -2 dilutions of the UV irradiated phage and the control phage in 0.85% NaCl. 7. Mix 200 µl of the IPTG induced culture with 100 µl of each phage dilution. 8. Leave at room temperature for about 20 min to allow phage adsorption. 9. To each mixture of cells + phage, add 3 ml TBSA top agar that has been melted then cooled to 50°C.
Mix gently then quickly pour onto an LB-agar plate and swirl the plate to cover the surface evenly. Allow the top agar to solidify for about 15 min at room temperature then incubate overnight at 37°C. 10. Examine the plates for clear plaques.
Purify clear plaque mutants
1. Subculture 0.1 ml of the overnight culture of TH564 cells with the P tac -DNA-binding protein expression plasmid into 2 ml LB-broth + antibiotic. Incubate with vigorous aeration at 37°C about 2-3 h until the cells reach mid-exponential phase.
2. Dilute 0.5 ml of the mid-exponential phase culture into 1.5 ml LB-broth + antibiotic + 1 mM IPTG. Incubate the cells for 1-2 h with vigorous aeration at 37°C. 3. Add 0.1 ml of the culture induced in LB-broth+ antibiotic + 1 mM IPTG to 3 ml TBSA that has been melted then cooled to 50°C. Mix gently then quickly pour onto an LB-broth+ 1 mM IPTG plate and swirl the plate to cover the surface evenly. Allow the top agar to solidify at room temperature. 4. Pick large clear plaques from challenge phage with an O c mutation in the DNA-binding site and streak on the cell lawn. Also streak out the unmutagenized challenge phage and P22-1000 as controls.
Incubate the plates at 37°C overnight. 5. The next day, add 0.1 ml of a fresh, overnight culture of MS1883 to 3 ml TBSA that has been melted and cooled to 50°C. Mix gently then quickly pour onto an LB-broth plate and swirl the plate to cover the surface evenly. Allow the top agar to solidify at room temperature. 6. Pick large clear plaques from step 4 and restreak on the MS1883 lawn. Incubate the plates at 37°C overnight. 7. Remove a well isolated large clear plaque from each streak with a sterile Pasteur pipet. 8. Add the agar plug to 2 ml LBEG. Vortex. Add 0.1 ml of an overnight culture of MS1883. Incubate with vigorous aeration at 37°C for about 3 h or until the culture lyses. 9. Centrifuge for 1 min in a microfuge to pellet the cells and debris. 10. Pour the supernatent into a clean tube. Add several drops of chloroform and vortex. 11. Titer the phage on MS1883. Assign allele numbers to the mutants and save pickates of the mutant phage lysates at 4°C. The DNA sequence of the mutations can be determined by PCR using the anti-O mnt and intra-Arc primers or by subcloning the EcoRI fragment which carries the Omnt substitution and mnt::Kan onto a plasmid and sequencing the plasmid DNA.
Bacteria and phage. The Salmonella typhimurium host strains for growing P22 challenge phage are shown in Table 1 . Although S. typhimurium can cause gastrointestinal infections in humans, the S. typhimurium LT2 strains used for challenge phage assays are not very virulent in humans (15, 16 A typical P22 lysate contains about 10 11 phage per ml and is stable for many years when stored over chloroform at 4°C. Lytic growth is favored when the host cells are growing rapidly and the multiplicity of infection (MOI) is low. Lysogeny is favored when cells are growing slowly and the MOI is high. When the MOI of P22 is greater than 10, more than 95% of the infected cells form lysogens (17) . P22 diffuses rapidly throughout a soft agar overlay on a petri dish upon extended storage. This can result in contamination of one plaque with phage from a nearby plaque. Therefore, to ensure the genetic homogeneity of phage lysates, recombinant phage should be purified by streaking for isolated, single plaques several times before growing large-scale lysates.
REAGENTS
Antibiotics: When needed, add antibiotics to LB medium at the following concentrations: 50 µg/ml kanamycin sulfate (Kan), 20 µg/ml tetracycline hydrochloride (Tet), 50 µg/ml sodium ampicillin (Amp), 50 µg/ml spectinomycin dihydrochloride. a Numerous other DNA-protein interactions have been studied as well. The critical requirement for any specific DNA-protein interaction is that the protein is expressed and active in Salmonella. 
